Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Regulação de mercados · 07/11/19951 min de leitura
The Upjohn Company and Pharmacia Aktiebolag; Consent Agreement With Analysis to Aid Public Comment
Tradução automática local · Idioma original da fonte
Resumo
In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition, this consent agreement, accepted subject to final Commission approval, would require The Upjohn Company and Pharmacia Aktiebolag to divest Pharmacia's assets in ``9-AC,'' a topoisomerase I inhibitor drug for the treatment of colorectal cancer, to a Commission-approved buyer who will ensure that research and development will continue in competition with the merged company's product ``CPT-11,'' a topoisomerase I inhibitor drug developed by Upjohn.
Idioma original da fonte: Federal Register — Federal Trade CommissionAbrir o comunicado original →